Medtronic plc (MDT) operating KPIs
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)
Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%
Medtronic cardiac Ablation Solutions (CAS) — U.S. Market Share Gain YoY (percentage points) (%)
Year-over-year U.S. market share gain in percentage points driven by PulseSelect and Affera Sphere-9 PFA catheters.
Latest, Q1 FY27
9.0%
Period ended Jul 31, 2026
Change on a year earlier
–
History
3 quarters
Since Q3 FY26
Sources
3
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Cardiac Ablation Solutions (CAS) — U.S. Market Share Gain YoY (percentage points) (%) | Year on year | Source |
|---|---|---|---|---|
| Q1 FY27 | Jul 31, 2026 | 9.0% | – | Medtronic FY2027Q1 Earnings Presentation ↗ |
| Q4 FY26 | Apr 30, 2026 | 8.0% | – | Medtronic FY2026Q4 Earnings Presentation ↗ |
| Q3 FY26 | Jan 31, 2026 | 4.0% | – | Medtronic FY2026Q3 CFO/CEO Earnings Commentary ↗ |
Cite this data
StockData. (2026). Medtronic Cardiac Ablation Solutions (CAS) — U.S. Market Share Gain YoY (percentage points) (%), quarterly Q3 FY26–Q1 FY27 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/cv-cas-us-share-pts
See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.